1. Home
  2. RCKT vs PHLT Comparison

RCKT vs PHLT Comparison

Compare RCKT & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • PHLT
  • Stock Information
  • Founded
  • RCKT 1999
  • PHLT 1976
  • Country
  • RCKT United States
  • PHLT United States
  • Employees
  • RCKT N/A
  • PHLT N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • PHLT Other Consumer Services
  • Sector
  • RCKT Health Care
  • PHLT Consumer Discretionary
  • Exchange
  • RCKT Nasdaq
  • PHLT Nasdaq
  • Market Cap
  • RCKT 326.4M
  • PHLT 267.0M
  • IPO Year
  • RCKT N/A
  • PHLT N/A
  • Fundamental
  • Price
  • RCKT $2.48
  • PHLT $4.04
  • Analyst Decision
  • RCKT Buy
  • PHLT
  • Analyst Count
  • RCKT 13
  • PHLT 0
  • Target Price
  • RCKT $18.50
  • PHLT N/A
  • AVG Volume (30 Days)
  • RCKT 4.7M
  • PHLT 208.2K
  • Earning Date
  • RCKT 08-04-2025
  • PHLT 08-06-2025
  • Dividend Yield
  • RCKT N/A
  • PHLT N/A
  • EPS Growth
  • RCKT N/A
  • PHLT N/A
  • EPS
  • RCKT N/A
  • PHLT N/A
  • Revenue
  • RCKT N/A
  • PHLT $128,916,000.00
  • Revenue This Year
  • RCKT N/A
  • PHLT $11.03
  • Revenue Next Year
  • RCKT N/A
  • PHLT $11.23
  • P/E Ratio
  • RCKT N/A
  • PHLT N/A
  • Revenue Growth
  • RCKT N/A
  • PHLT 11.76
  • 52 Week Low
  • RCKT $2.19
  • PHLT $2.17
  • 52 Week High
  • RCKT $26.98
  • PHLT $4.35
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 31.96
  • PHLT N/A
  • Support Level
  • RCKT $2.50
  • PHLT N/A
  • Resistance Level
  • RCKT $2.70
  • PHLT N/A
  • Average True Range (ATR)
  • RCKT 0.20
  • PHLT 0.00
  • MACD
  • RCKT 0.11
  • PHLT 0.00
  • Stochastic Oscillator
  • RCKT 4.82
  • PHLT 0.00

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About PHLT Performant Healthcare Inc. Common Stock

Performant Healthcare Inc provides solutions to payers in the healthcare industry to identify, prevent, and recover waste and improper payments by leveraging technology, analytics, and proprietary data assets.

Share on Social Networks: